Abstracts and Available Papers Presented at the 2002 International RERTR Meeting
CONSIDERATIONS IN THE DESIGN OF A HIGH POWER MEDICAL
ISOTOPE PRODUCTION REACTOR
Russell M. Ball
Ball Systems Company
Lynchburg,
Virginia USA
H. William Nordyke, CEO, TCI
Roy Brown, VP, TCI
Albuquerque, New
Mexico
ABSTRACT
For the low
enriched aqueous homogeneous reactor to be economic in the production of
medical isotopes, such as Mo-99 and Sr-89, the power level should be of the
order of 100 kWth. This is double the earlier designs and this paper discusses
the design changes which must be considred to meet this goal.
The topics considered are:
Heat removal from the reactor solution
Recombination
of radiolytic gases
Adequate
radiation shielding
Stability
of reactor power with fluctuating reactivity
Contact: Dr. Russell M. Ball President Ball Systems Company 1620 Belfield Place Lynchburg, VA 24503, USA Phone: (1 434) 384 1572 Fax: (1 434) 384 3318 E-mail: [email protected]
The 2016 International RERTR Meeting (RERTR-2016) will take place in Belgium.
Stay tuned for further details.
The 2015 International RERTR Meeting (RERTR-2015) took place in Seoul, Korea on Oct. 11-14, 2015.
For more information visit RERTR-2015.